Provided by Tiger Trade Technology Pte. Ltd.

Orgenesis, Inc.

0.5167
-0.0583-10.15%
Volume:1.69K
Turnover:731.98
Market Cap:2.67M
PE:-0.06
High:0.6000
Open:0.6000
Low:0.2500
Close:0.5750
52wk High:5.89
52wk Low:0.0001
Shares:5.17M
Float Shares:4.61M
Volume Ratio:17.23
T/O Rate:0.04%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-9.2916
EPS(LYR):-19.0848
ROE:-727.25%
ROA:-68.49%
PB:-0.11
PE(LYR):-0.03

Loading ...

Company Profile

Company Name:
Orgenesis, Inc.
Exchange:
EXPERT
Establishment Date:
2008
Employees:
146
Office Location:
20271 Goldenrod Lane,Germantown,Maryland,United States
Zip Code:
20876
Fax:
- -
Introduction:
Orgenesis Inc., a biotech company, focuses on cell and gene therapies worldwide. It operates through two segments, Octomera and Therapies. The company develops a Point of Care (POCare) platform that includes a pipeline of licensed cell based POCare therapies that are processed and produced under closed and automated POCare technology systems across a collaborative POCare network consisting of research institutes and hospitals. Its therapies include autologous; cell-based immunotherapies; and therapeutics for metabolic diseases, anti-viral diseases, and tissue regeneration. The company also provides development services, including regulatory services, pre-clinical studies, intellectual property services, and GMP process translation, as well as support services; hospital services; cell process development services; and distributed cell processing services. The company was formerly known as Business Outsourcing Service, Inc. and changed its name to Orgenesis Inc. in August 2011. Orgenesis Inc. was incorporated in 2008 and is headquartered in Germantown, Maryland.